Traws Pharma
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Traws Pharma's past years’ income statements indicate that its last revenue has compared to the previous period by 0% to $226,000. The net income raised on -$18,948,000 and profit margin reached -8384%. Total operating expenses were $20,508,000.
Profit Margin
| 2014 | 800K | -63.68M | -7960.25% |
|---|---|---|---|
| 2015 | 11.45M | -23.97M | -209.31% |
| 2017 | 787K | -24.09M | -3061.25% |
| 2019 | 2.18M | -21.50M | -985.02% |
| 2020 | 231K | -25.15M | -10890.48% |
| 2021 | 226K | -16.16M | -7151.77% |
| 2022 | 226K | -18.96M | -8391.15% |
| 2023 | 226K | -18.94M | -8384.07% |
TRAW Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||
Revenue | 226K | 226K | 226K | 231K | 2.18M | 787K | 11.45M | 800K |
Cost of revenue | 16K | 14K | 14K | 0 | 0 | 0 | 0 | 0 |
Gross profit | 210K | 212K | 212K | 231K | 2.18M | 787K | 11.45M | 800K |
Operating exp. | ||||||||
Research and development | 11.41M | 11.40M | 7.29M | 16.89M | 15.52M | 19.03M | 25.89M | 49.42M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 20.50M | 19.85M | 16.72M | 25.22M | 23.86M | 26.43M | 35.42M | 64.54M |
Operating income | -20.29M | -19.62M | -16.49M | -24.99M | -21.69M | -25.73M | -23.97M | -63.74M |
Other income (expenses), net | 1.35M | 663K | 333K | -160K | 206K | 1.65M | -35K | -32K |
Income before tax | -18.94M | -18.96M | -16.16M | -25.15M | -21.49M | -24.07M | -24.00M | -63.77M |
Income tax expense | 0 | 0 | -321K | 4K | 10K | 13K | 16K | 19K |
Net income | -18.94M | -18.96M | -16.16M | -25.15M | -21.50M | -24.09M | -23.97M | -63.68M |
Earnings per share | ||||||||
Basic EPS | -0.9 | -0.91 | -0.96 | -2.17 | -22.42 | -602.28 | -53.05K | -165.40K |
Diluted EPS | -0.9 | -0.91 | -0.96 | -2.17 | -22.42 | -602.28 | -53.05K | -165.40K |